Akums Drugs & Pharmaceuticals Ltd Quarterly Result

Akums Drugs & Pharmaceuticals Ltd Quarterly Result

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

Net Profit - Last Quarter

₹ 81.34 Cr.

Last updated on: Jun 14, 2026

Akums Drugs & Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Akums Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 1193 crore as compare to the Dec '25 revenue of ₹ 1193 crore.
  • This represent the decline of -0.06% The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 185.23 crore as compare to the Dec '25 ebitda of ₹ 162.96 crore.
  • This represent the growth of 13.67% The net profit of Akums Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 81.34 crore as compare to the Dec '25 net profit of ₹ 67.67 crore.
  • This represent the growth of 20.2%.

Akums Drugs & Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Akums Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Akums Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Jun 2026622.95
11 Jun 2026608.65
10 Jun 2026592.35
09 Jun 2026548.6
08 Jun 2026546.65
05 Jun 2026553.9
04 Jun 2026556.1
03 Jun 2026539.65
02 Jun 2026530.15
01 Jun 2026524.05

Historical Revenue of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Akums Drugs & Pharmaceuticals Ltd News Hub

Akums Drugs and Pharmaceuticals rises on debut

The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the stock has

Read more

06 Aug 24

Akums Drugs and Pharmaceuticals IPO ends with strong subscription

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bids for sha

Read more

02 Aug 24

Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bids for sha

Read more

01 Aug 24

Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter

Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 202

Read more

26 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

FAQs for Quarterly Results of Akums Drugs & Pharmaceuticals Ltd

What key financial metrics are included in Akums Drugs & Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Akums Drugs & Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Akums Drugs & Pharmaceuticals Ltd announce its quarterly results?

Akums Drugs & Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Akums Drugs & Pharmaceuticals Ltd's quarterly performance impact its stock price?

Akums Drugs & Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Akums Drugs & Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Akums Drugs & Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Akums Drugs & Pharmaceuticals Ltd's quarterly results?

Yes, Akums Drugs & Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions